[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-369741-105":59,"doc-detail-369741-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","detection-of-brain-cancer-using-genome-wide-cell-free-dna-fragmentomes","Detection of Brain Cancer Using Genome-wide Cell-free DNA Fragmentomes","","Diagnostic delays in brain cancer patients are common and can worsen outcomes, highlighting the need for faster, noninvasive testing. This study develops and evaluates a blood-based approach using genome-wide cell-free DNA (cfDNA) fragmentome features, including fragmentation profiles and repeat landscapes. Machine learning identifies brain cancer across all-grade gliomas with AUC 0.90 (95% CI 0.87–0.93) and is validated in an independent prospectively collected cohort. Fragmentome changes reflect both glioma-derived fragmentation and altered white blood cell populations, enabling new noninvasive detection avenues.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/detection-of-brain-cancer-using-genome-wide-cell-free-dna-fragmentomes/369741/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/detection-of-brain-cancer-using-genome-wide-cell-free-dna-fragmentomes/369741.png","ImageObject",300,407,{"name":92,"@type":93},"McQueen","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-29","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":29},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"Why is earlier detection of brain cancer difficult today?","Question",{"text":112,"@type":113},"Diagnostic delays are common, and symptoms are nonspecific, leading to misses in emergency or primary care screening. Imaging practices vary, and many patients either receive unnecessary scans or do not get imaging promptly.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"What approach does the study propose for brain cancer detection?",{"text":117,"@type":113},"The study analyzes genome-wide cfDNA fragmentomes from blood plasma, using fragmentation profiles and repeat landscapes. Machine learning is applied to fragmentome features to detect brain cancer.",{"name":119,"@type":110,"acceptedAnswer":120},"How well did the machine learning model perform, and was it validated?",{"text":121,"@type":113},"The model detected brain cancer across all-grade gliomas with AUC 0.90 (95% confidence interval 0.87–0.93). Results were validated in an independent prospectively collected cohort.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},369741,1790332907,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":29,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":36,"preview_page_count":19,"preview_urls":145},5909890329169,"https://ap-avatar.wpscdn.com/davatar_9964176cb1d06d4a9deccf72a44ae3dc","ReseaRch aRticle   \nDetection of Brain Cancer Using  \nGenome-wide Cell-free DNA Fragmentomes   \nDimitrios Mathios1,2,3, Noushin Niknafs1, Akshaya V. Annapragada1, Ernest J. Bobeff4,5, Elaine J. Chiao1,  \nKavya Boyapati1, Keerti Boyapati1, Sarah Short1, Adrianna L. Bartolomucci1, Stephen Cristiano1,  \nShashikant Koul1, Nicholas A. Vulpescu1, Leonardo Ferreira1, Jamie E. Medina1, Daniel C. Bruhm1,  \nVilmos Adleff1, Małgorzata Podstawka4, Patrycja Stanisławska4, Chul-Kee Park6, Judy Huang7,  \nGary L. Gallia7, Henry Brem7, Debraj Mukherjee7, Justin M. Caplan7, Jon Weingart7, Christopher M. Jackson7,  \nMichael Lim8, Jillian Phallen1, Robert B. Scharpf1, and Victor E. Velculescu1  \nDiagnostic delays in patients with brain cancer are common and can impact patient  \noutcome. Development of a blood-based assay for detection of brain cancers could accelerate brain cancer diagnosis. In this study, we analyzed genome-wide cell-free (cfDNA) fragmentomes, including fragmentation profiles and repeat landscapes, from the plasma of individuals with (n = 148) or without (n = 357) brain cancer. Machine learning analyses of cfDNA fragmentome features detected brain cancer across all-grade gliomas (AUC = 0.90; 95% confidence interval, 0.87–0.93), and these results were validated in an independent prospectively collected cohort. cfDNA fragmentome changes in patients with gliomas represented a combination of fragmentation profiles from glioma cells and altered white blood cell populations in the circulation. These analyses reveal the properties of cfDNA in patients with brain cancer and open new avenues for noninvasive detection of these individuals.  \nSiGNiFiCANCe: Brain cancer is one of the deadliest and most challenging cancers to detect with liquid biopsy approaches in blood, hampering efforts for earlier noninvasive diagnosis. We have developed a machine learning genome-wide cfDNA fragmentation method that provides a sensitive and accessible approach for brain cancer detection.  \nintRoduction  \nApproximately 19,000 individuals are estimated to die annually in the United States from primary brain cancer (1) . There are currently no screening efforts for early detection of brain cancer at the asymptomatic phase of the disease. Symptoms suggestive of a potential neurologic issue, such as headache, nausea, dizziness, memory difficulties, or subtle cognitive and personality changes, are nonspecific, and studies have documented significant delays in brain tumor detection from the time of first symptom onset to diagnosis (2–5) . Due to the lack of specificity of symptoms for brain tumor detection, the guidelines for screening of patients presenting to the emergency room or their primary care doctor with neurologic symptoms frequently fail to capture patients with brain tumorsat first presentation.  \n1Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, Maryland. 2Department of Neurosurgery, Washington University in St Louis, School of Medicine, St Louis, Missouri.  \n3Siteman Cancer Center, Washington University in St Louis, St Louis, Missouri. 4Department of Neurosurgery and Neurooncology, Medical University of Lodz, Barlicki University Hospital, Lodz, Poland. 5Department of Sleep Medicine and Metabolic Disorders, Medical University of Lodz, Lodz, Poland. 6Department of Neurosurgery, Seoul National University College of Medicine, Seoul, Korea. 7Department of Neurosurgery, Johns Hopkins University School of Medicine, Baltimore, Maryland. 8Department of Neurosurgery, Stanford University, Palo Alto, California.  \nD. Mathios and N. Niknafs contributed equally to this article.  \nCorresponding Authors: Dimitrios Mathios, Siteman Cancer Center, Washington University School of Medicine, 660 South Euclid Avenue, Box 8057, St. Louis, [MO 63110. E-mail: mathios@wustl.edu](MO 63110. E-mail: mathios@wustl.edu); and Victor E. Velculescu, The Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of M","cbCaioPSiXXfQV0L","https://ap.wps.com/l/cbCaioPSiXXfQV0L","pdf",7217640,16,"English","# Introduction\n## Diagnostic delay and current screening gaps\n## Imaging practices and clinical need\n## Liquid biopsy approaches and limitations","[{\"question\":\"Why is earlier detection of brain cancer difficult today?\",\"answer\":\"Diagnostic delays are common, and symptoms are nonspecific, leading to misses in emergency or primary care screening. Imaging practices vary, and many patients either receive unnecessary scans or do not get imaging promptly.\"},{\"question\":\"What approach does the study propose for brain cancer detection?\",\"answer\":\"The study analyzes genome-wide cfDNA fragmentomes from blood plasma, using fragmentation profiles and repeat landscapes. Machine learning is applied to fragmentome features to detect brain cancer.\"},{\"question\":\"How well did the machine learning model perform, and was it validated?\",\"answer\":\"The model detected brain cancer across all-grade gliomas with AUC 0.90 (95% confidence interval 0.87–0.93). Results were validated in an independent prospectively collected cohort.\"}]","Detection of Brain Cancer Using Genome-wide Cell-free DNA Fragmentomes | PDF",1790184312,[146,150,154,158],{"page_no":8,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/78251fd5bd7fd5d857030bf11936ae90.webp",983,1315,{"page_no":14,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/18bed8ad512b44a247a0807b3c53938b.webp",982,1314,{"page_no":81,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/d4afe639857411c8e56062fb441f340e.webp",981,1312,{"page_no":19,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/37d98baf50bff5c01d767ee693463ce6.webp",980,1311]